A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS)
- PMID: 20573754
- PMCID: PMC2928372
- DOI: 10.2337/dc10-0679
A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS)
Abstract
Objective: A1C is an optional method for diagnosing diabetes and also for detecting individuals at increased risk of the disease. However, how A1C compares with fasting (FPG) and 2-h plasma glucose for detecting at-risk individuals is not well known.
Research design and methods: A 2-h glucose tolerance test, frequently sampled intravenous glucose tolerance test, and A1C were obtained at the follow-up examination in 855 participants in the Insulin Resistance Atherosclerosis Study (IRAS). For this report, 385 individuals were at increased risk of diabetes as defined by A1C between 5.7 and 6.4%, impaired glucose tolerance (IGT), and/or impaired fasting glucose (IFG).
Results: IFG and IGT identified 69.1 and 59.5% of all individuals at increased risk of diabetes, respectively. A1C 5.7-6.4% detected 23.6% of all at-risk individuals, although more African Americans (31.4%) and Hispanics (35.2%) than non-Hispanic whites (9.9%). Relative to A1C, FPG was more strongly related to fasting insulin (r = 0.38 vs. 0.26; P < 0.01), acute insulin response (r = - 0.20 vs. - 0.09; P < 0.01), and waist circumference (r = 0.43 vs. 0.25; P < 0.001) by the Spearman correlation test. Similarly, 2-h plasma glucose was more strongly related to Si (r = - 0.40 vs. - 0.27; P < 0.01) and triglycerides (r = 0.30 vs. 0.08; P < 0.001).
Conclusions: A1C 5.7-6.4% is less sensitive for detecting at-risk individuals than IFG and IGT, particularly among non-Hispanic whites. Single determinations of FPG and 2-h plasma glucose seem to be more precise correlates of insulin resistance and secretion than A1C and, in general, better for other metabolic disorders.
Figures

Similar articles
-
Prediabetic increase in hemoglobin A1c compared with impaired fasting glucose in patients receiving antipsychotic drugs.Eur Neuropsychopharmacol. 2013 Mar;23(3):205-11. doi: 10.1016/j.euroneuro.2012.05.002. Epub 2012 May 29. Eur Neuropsychopharmacol. 2013. PMID: 22652493
-
Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.Diabetes. 2004 Jun;53(6):1549-55. doi: 10.2337/diabetes.53.6.1549. Diabetes. 2004. PMID: 15161760
-
Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):334-9. doi: 10.1055/s-2005-865680. Exp Clin Endocrinol Diabetes. 2005. PMID: 15977101
-
Classification and Diagnosis of Diabetes.In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug. CHAPTER 1. In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug. CHAPTER 1. PMID: 33651569 Free Books & Documents. Review.
-
Review of methods for detecting glycemic disorders.Diabetes Res Clin Pract. 2020 Jul;165:108233. doi: 10.1016/j.diabres.2020.108233. Epub 2020 Jun 1. Diabetes Res Clin Pract. 2020. PMID: 32497744 Free PMC article. Review.
Cited by
-
Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study.J Endocrinol Invest. 2012 Oct;35(9):835-40. doi: 10.3275/8191. Epub 2011 Dec 16. J Endocrinol Invest. 2012. PMID: 22186659
-
Performance of diabetes screening tests: an evaluation study of Iranian diabetes screening program.Diabetol Metab Syndr. 2021 Jan 26;13(1):13. doi: 10.1186/s13098-021-00632-9. Diabetol Metab Syndr. 2021. PMID: 33499908 Free PMC article.
-
Broader Screening for Youth-Onset Type 2 Diabetes-We Just Are Not There Yet.JAMA Netw Open. 2022 Sep 1;5(9):e2220540. doi: 10.1001/jamanetworkopen.2022.20540. JAMA Netw Open. 2022. PMID: 36098974 Free PMC article. No abstract available.
-
Issues in Defining the Burden of Prediabetes Globally.Curr Diab Rep. 2018 Sep 19;18(11):105. doi: 10.1007/s11892-018-1089-y. Curr Diab Rep. 2018. PMID: 30229351 Review.
-
Implications of alternative definitions of prediabetes for prevalence in U.S. adults.Diabetes Care. 2011 Feb;34(2):387-91. doi: 10.2337/dc10-1314. Diabetes Care. 2011. PMID: 21270196 Free PMC article.
References
-
- Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E: DESIR Study Group. Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006;29:1619–1625 - PubMed
-
- Inoue K, Matsumoto M, Akimoto K: Fasting plasma glucose and HbA1c as risk factors for type 2 diabetes. Diabet Med 2008;25:1157–1163 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical